Presentation + Paper
4 April 2022 Multimodal region-based transformer for the classification and prediction of Alzheimer's disease
Author Affiliations +
Abstract
Numerous deep learning approaches have been proposed to automatically classify Alzheimer’s disease (AD) from medical images. However, common approaches, such as convolutional neural networks (CNNs), lack interpretability and are prone to over-fitting when trained on small datasets. As an alternative, significantly less work has explored applying deep learning approaches to region-based features commonly obtained from atlas partitions of known regions of interest (ROI). In this paper, we propose a self-attention mechanism to jointly learn a graph of ROI connectivity as a prior for learning meaningful features for AD prediction. We apply our method to both the classification of AD subjects from healthy controls and to predict whether mild cognitive impaired (MCI) subjects will progress to AD (pMCI) or not (sMCI). We systematically show that our model’s performance compares well with other common ML approaches for ROI-based methods, such as neural networks and support vector machines. Finally, we perform exploratory graph analysis to illustrate the interpretability properties of the attention graphs and how they can provide insight for scientific discovery.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Kevin Mueller, Anke Meyer-Baese, and Gordon Erlebacher "Multimodal region-based transformer for the classification and prediction of Alzheimer's disease", Proc. SPIE 12036, Medical Imaging 2022: Biomedical Applications in Molecular, Structural, and Functional Imaging, 120361B (4 April 2022); https://doi.org/10.1117/12.2611793
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Alzheimer's disease

Head

Data modeling

Machine learning

Brain

Image segmentation

Neuroimaging

Back to Top